Matching slides 303,780
Current window 229,771-229,800
Pages 10,126
Rows per page 30
Component: Titleclear collectionreset all

Component

229,771-229,800 of 303,780

filter-aware
13
The chart uses a trend line to emphasize the growth trajectory.Freightos | Investor Presentation Deck | 35 slides · Freightos
Pitch deck Investor relations Beat · Traction1 hit
14
The slide uses callouts to annotate specific UI elements of the WebCargo booking interface.Freightos | Investor Presentation Deck | 35 slides · Freightos
Pitch deck Investor relations Beat · Traction1 hit
15
The slide uses callouts to annotate specific UI elements of the platform.Freightos | Investor Presentation Deck | 35 slides · Freightos
Pitch deck Investor relations Beat · Traction1 hit
16
The slide uses a screenshot of the software interface with callouts pointing to specific features like trade lane data, market events, and transit time reports.Freightos | Investor Presentation Deck | 35 slides · Freightos
Pitch deck Investor relations Beat · Traction1 hit
17
Freightos | Investor Presentation Deck | 35 slidesFreightos | Investor Presentation Deck | 35 slides · Freightos
Pitch deck Investor relations Beat · Traction1 hit
18
The chart tracks the percentage of bookings placed by forwarder cohorts relative to their initial first-quarter bookings.Freightos | Investor Presentation Deck | 35 slides · Freightos
Pitch deck Investor relations Beat · Traction1 hit
19
Freightos | Investor Presentation Deck | 35 slidesFreightos | Investor Presentation Deck | 35 slides · Freightos
Pitch deck Investor relations Beat · Financials1 hit
20
The slide uses a flywheel concept to frame the growth metrics.Freightos | Investor Presentation Deck | 35 slides · Freightos
Pitch deck Investor relations Beat · Financials1 hit
21
The slide illustrates the dual revenue stream model of the company.Freightos | Investor Presentation Deck | 35 slides · Freightos
Pitch deck Investor relations Beat · Financials1 hit
22
The slide uses a combination of a grouped bar chart for internal financial performance and a single-series bar chart for competitive benchmarking.Freightos | Investor Presentation Deck | 35 slides · Freightos
Pitch deck Investor relations Beat · Financials1 hit
23
The slide uses two bar charts to demonstrate improving financial health.Freightos | Investor Presentation Deck | 35 slides · Freightos
Pitch deck Investor relations Beat · Financials1 hit
25
Freightos | Investor Presentation Deck | 35 slidesFreightos | Investor Presentation Deck | 35 slides · Freightos
Pitch deck Investor relations Beat · Financials1 hit
26
This is a closing slide for an investor presentation.Freightos | Investor Presentation Deck | 35 slides · Freightos
Pitch deck Investor relations Loop · Quick Win Big Bet1 hit
27
Freightos | Investor Presentation Deck | 35 slidesFreightos | Investor Presentation Deck | 35 slides · Freightos
Pitch deck Investor relations Loop · Quick Win Big Bet1 hit
29
The table includes a significant one-time share listing expense in Q1 2023.Freightos | Investor Presentation Deck | 35 slides · Freightos
Pitch deck Investor relations 1 hit
30
The table shows adjustments for non-cash and non-recurring items to arrive at Adjusted EBITDA.Freightos | Investor Presentation Deck | 35 slides · Freightos
Pitch deck Investor relations 1 hit
31
The table reconciles IFRS gross profit to non-IFRS gross profit by adding back share-based compensation and depreciation & amortization.Freightos | Investor Presentation Deck | 35 slides · Freightos
Pitch deck Investor relations 1 hit
32
Values are in $K. The table shows a trend of increasing revenue alongside increasing operating losses.Freightos | Investor Presentation Deck | 35 slides · Freightos
Pitch deck Investor relations 1 hit
33
The table adjusts IFRS gross profit by adding back share-based compensation and depreciation & amortization to arrive at Non-IFRS gross profit.Freightos | Investor Presentation Deck | 35 slides · Freightos
Pitch deck Investor relations 1 hit
34
The table details non-GAAP adjustments including share-based compensation, D&A, and various one-time costs.Freightos | Investor Presentation Deck | 35 slides · Freightos
Pitch deck Investor relations 1 hit
35
Freightos | Investor Presentation Deck | 35 slidesFreightos | Investor Presentation Deck | 35 slides · Freightos
Pitch deck Investor relations 1 hit
01
Slide 1
Fusion Pharmaceuticals | Investor Presentation Deck | 26 slidesFusion Pharmaceuticals | Investor Presentation Deck | 26 slides · Fusion Pharmaceuticals
Pitch deck Investor relations 1 hit
02
Fusion Pharmaceuticals | Investor Presentation Deck | 26 slidesFusion Pharmaceuticals | Investor Presentation Deck | 26 slides · Fusion Pharmaceuticals
Pitch deck Investor relations 1 hit
04
Fusion Pharmaceuticals | Investor Presentation Deck | 26 slidesFusion Pharmaceuticals | Investor Presentation Deck | 26 slides · Fusion Pharmaceuticals
Pitch deck Investor relations Beat · Problem1 hit
05
The slide uses a before/after PET scan visual to demonstrate clinical efficacy.Fusion Pharmaceuticals | Investor Presentation Deck | 26 slides · Fusion Pharmaceuticals
Pitch deck Investor relations Beat · Problem1 hit
06
The slide uses a process diagram to show the evolution of the FPI-2265 program.Fusion Pharmaceuticals | Investor Presentation Deck | 26 slides · Fusion Pharmaceuticals
Pitch deck Investor relations Beat · Solution1 hit
08
Uses a combination of clinical trial data (VISION) and market projections to justify the TAM for FPI-2265.Fusion Pharmaceuticals | Investor Presentation Deck | 26 slides · Fusion Pharmaceuticals
Pitch deck Investor relations Beat · Solution1 hit
09
Fusion Pharmaceuticals | Investor Presentation Deck | 26 slidesFusion Pharmaceuticals | Investor Presentation Deck | 26 slides · Fusion Pharmaceuticals
Pitch deck Investor relations Beat · Solution1 hit
10
Fusion Pharmaceuticals | Investor Presentation Deck | 26 slidesFusion Pharmaceuticals | Investor Presentation Deck | 26 slides · Fusion Pharmaceuticals
Pitch deck Investor relations 1 hit
11
The slide uses a comparative structure to highlight the superiority of alpha particles in DNA damage and clinical logistics.Fusion Pharmaceuticals | Investor Presentation Deck | 26 slides · Fusion Pharmaceuticals
Pitch deck Investor relations Loop · Cost Of Inaction1 hit